Pulmonary Function after Proton Therapy for Hodgkin Lymphoma

PURPOSE: Acute and late toxicity from chemotherapy, targeted therapy, and radiation therapy can cause significant morbidity among survivors of Hodgkin lymphoma (HL), including pulmonary dysfunction. Improved dosimetry may influence pulmonary function tests (PFTs), an objective and clinically signifi...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Int J Part Ther
Egile Nagusiak: O'steen, Lillie, Bellardini, Jason, Cury, James, Jones, Lisa, Seeram, Vandana K., Mendenhall, Nancy P., Hoppe, Bradford S.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: The Particle Therapy Co-operative Group 2019
Gaiak:
Original Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6874186/
https://ncbi.nlm.nih.gov/pubmed/31788502
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14338/IJPT-18-00040.1
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak